Company Ticker News December 23, 2021Novavax (NVAX) COVID-19 Booster Jab Effective Against Omicron 0 0 Share
Company Ticker News December 22, 2021Novavax Initiates Phase 3 COVID-19 Vaccine Booster Study 0 0 Share
Press Release December 22, 2021Thornton Law Firm Reminds Novavax, Inc. (NVAX) Investors of Securities Class Action Lawsuit 0 0 Share
Company Ticker News December 20, 2021Novavax Climbs as Its Covid Vaccine Recommended for EU Approval 0 0 Share
Press Release December 20, 2021NVAX Stock Alert: 2 Big Reasons Novavax Is Shooting Higher Today 0 0 Share
Press Release December 20, 2021Novavax To Possibly Kickstart COVID-19 Vaccine Delivery To EU In Q1 2022: Source 0 0 Share
Press Release December 20, 2021HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys 0 0 Share
Company Ticker News December 20, 2021Novavax Covid-19 Vaccine Wins Approval From European Union Regulator 0 0 Share
